Novel half‐life extended anti‐MIF nanobodies protect against endotoxic shock-Reference-Cited by-同舟云学术

Novel half‐life extended anti‐MIF nanobodies protect against endotoxic shock

Published:2018-01-25 Issue:6 Volume:32 Page:3411-3422
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Sparkes Amanda¹²,De Baetselier Patrick¹²,Brys Lea¹²,Cabrito Inês³⁴,Sterckx Yann G.-J.¹,Schoonooghe Steve¹²,Muyldermans Serge¹,Raes Geert¹²,Bucala Richard⁵,Vanlandschoot Peter⁴⁶,Van Ginderachte Jo A.¹²,Stijlemans Benoît¹²

Affiliation:

1. Laboratory of Cellular and Molecular ImmunologyVrije Universiteit Brussels Brussels Belgium

2. Myeloid Cell Immunology LaboratoryFlanders Institute for Biotechnology (VIB) Center for Inflammation Research Brussels Belgium

3. Department of BiopharmaceuticalsPharmaceutical Product Development (PPD) LaboratoriesGood Manufacturing Practices (GMP) Laboratory Athlone Ireland

4. Ablynx NV Zwijnaarde Belgium

5. Department of Internal MedicineYale University School of Medicine New Haven Connecticut USA

6. N-Spired Aalter Belgium

Funder

National Research Foundation Singapore

Australia-India Strategic Research Fund

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201701189R

Reference74 articles.

1. Why immunomodulatory therapies have not worked in sepsis

2. MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development

3. MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis

4. Macrophage migration inhibitory factor: a regulator of innate immunity

5. MIF Signal Transduction Initiated by Binding to CD74

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyvalency: an emerging trend in the development of clinical antibodies;Drug Discovery Today;2024-01

2. Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review;Neuro-Oncology Advances;2024-01-01

3. A few good reasons to use nanobodies for cancer treatment;European Journal of Immunology;2023-06-27

4. Nanobodies: Robust miniprotein binders in biomedicine;Advanced Drug Delivery Reviews;2023-04

5. Hallmarks of Cancer Affected by the MIF Cytokine Family;Cancers;2023-01-06